LPL Financial
TIL icon

LPL Financial’s Instil Bio TIL Stock Holding History

LPL Financial’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$264K Sell
32,063
-1,017
-3% -$8.25K ﹤0.01% 5283
2025
Q4 		$364K Sell
33,080
-607
-2% -$8.98K ﹤0.01% 4992
2025
Q3 		$602K Buy
+33,687
New +$855K ﹤0.01% 4474

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

LPL Financial's TIL Position: Q1 2026 in Review

LPL Financial reduced its Instil Bio (TIL) stake by 3.1% in Q1 2026, selling an estimated $8.25K and leaving 32,063 shares worth $264K. The position accounts for ﹤0.01% of the portfolio, ranked #5283.

LPL Financial first reported a position in TIL in Q3 2025 and has held it in 3 quarters since. The position peaked at $602K in Q3 2025. 32 funds tracked by Wall St. Rank hold TIL as of Q1 2026.

  • LPL Financial held 32,063 shares of Instil Bio worth $264K as of Q1 2026.
  • LPL Financial sold 1,017 Instil Bio shares in Q1 2026, an estimated $8.25K.
  • Instil Bio made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #5283 holding.
  • LPL Financial first reported a position in Instil Bio in Q3 2025 and has held it in 3 quarters since.
  • LPL Financial's Instil Bio position peaked at $602K in Q3 2025.
  • 32 funds tracked by Wall St. Rank held Instil Bio as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.